特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
962196

ヘルスケア分析試験サービスの世界市場:2020年-2027年

Global Healthcare Analytical Testing Services Market - 2020-2027

出版日: | 発行: DataM Intelligence | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.41円
ヘルスケア分析試験サービスの世界市場:2020年-2027年
出版日: 2020年09月25日
発行: DataM Intelligence
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

ヘルスケア分析試験サービスは、医薬品開発の全段階をサポートするもので、医薬品、生物医薬品、医療機器のメーカーにより広く利用されています。これらのサービスは、創薬から臨床開発、臨床試験、商業化に至るまでの医薬品開発の過程をサポートするもので、プロセスをシステム化し、ヘルスケアセクター全体の発展に必要なデータを取得するため、患者の記録、コスト、病院管理、診断などについての情報を得ることが目的です。

市場拡大の原動力となるのは、バイオシミラーや生物製剤の分析試験の増加、製薬企業による分析試験アウトソーシングの増加、医薬品開発におけるクオリティバイデザイン(QbD)手法の導入拡大などの要因です。

当レポートは、世界のヘルスケア分析試験サービス市場を調査したもので、市場の力学、業界の分析、エンドユーザー別、地域別の分析、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 調査手法と範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
  • 影響分析
  • 市場機会

第5章 業界の分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析
  • 価格分析
  • 製品分析
  • 市販後サービス分析
  • COVID-19の影響分析

第6章 試験タイプ別の市場

  • イントロダクション
  • 市場規模と前年比成長率の分析
  • 市場魅力指数
    • 生物学的分析試験サービス*
    • 試験法の開発と検証
    • 安定性試験
    • 原薬
    • その他

第7章 エンドユーザー別の市場

  • イントロダクション
  • 市場規模と前年比成長率の分析
  • 市場魅力指数
    • 医療機器企業
    • 開発業務受託機関

第8章 地域別の市場

  • イントロダクション
  • 市場規模と前年比成長率の分析
  • 市場魅力指数
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第9章 競合情勢

  • 競合シナリオ
  • 市場でのポジショニング/シェア分析
  • 合併と買収の分析

第10章 企業プロファイル

  • Laboratory Testing Inc *
  • Eurofins Scientific
  • SGS SA
  • Toxikon Inc.
  • Pace Analytical Services
  • Intertek Pharmaceutical Services
  • Boston Analytical
  • West Pharmaceutical Services Inc. a
  • Steris
  • Charles River Laboratories
  • List is not exhaustive

第11章 主な調査結果

第12章 世界のヘルスケア分析テスト市場

目次

Market Overview

Healthcare analytical testing services are widely used by pharmaceutical, biopharmaceutical, and medical device manufacturers that support throughout the stages of their drug development. These services provide support in the process of drug development started from discovery through clinical development or clinical trials to commercial use. The primary objective of performing healthcare analytics is to gain insights into patient records, costs, hospital management, and diagnosis in order to systemize the process and obtain required data for the development of the overall healthcare sector. Furthermore, analytical testing plays a critical role in the end-to-end process of drug development and manufacturing.

This service provides support in the process of drug development started from discovery through clinical development or clinical trials to commercial use.

Market Dynamics:

The market is driven is the demand for research and development outsourcing. Healthcare analytical testing services are extensively used by biopharmaceutical, pharmaceutical, and medical device manufacturers to support throughout the stages of their drug development.

Increasing analytical testing rate of biosimilar and biologics, rising outsourcing of analytical testing by several pharmaceutical companies, and growing acceptance of Quality by design (QbD) approach in pharma manufacturing are believed to be driving the global healthcare analytical testing services market. QbD helps various pharmaceutical companies in adopting data-driven, systemic strategies in order to deliver quality outcomes. Many biotechnology and pharmaceutical companies are opting for outsourcing analytical testing services for reducing the time and cost of the manufacturing process. Thus, rising adoption of FTE contracts in research and development outsourcing also expected to boost the global healthcare analytical testing services market.

Furthermore, the demand for bioanalytical testing is rising due to the growing number of drugs in biopharmaceutical pipeline, and rising biopharmaceutical industry across the world, which in turn is also expected to fuel the global healthcare analytical testing services market. Apart from all these, rising analytical testing service outsourcing by biopharmaceutical companies for boosting their profit margins, reducing the required time for validating the product and process, and avoiding high capital expenditure are also projected to propel the global healthcare analytical testing services market.

According to the International Journal of Environmental Research and Public Health's published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and ensure safety. Medicines are intended for better outcome in humans and animals. However, poor quality of medicines would not only affect adversely on the health of the patients but also on the fund systems. Therefore, to ensure safety and efficacy of the drugs analytical testing holds an important role.

However, data insecurity is the main factor which hinder the growth of the market in the forecast period

Moreover, COVID-19 pandemic has also affected the market adversely. For instance, after COVID-19 was declared as a pandemic by the WHO, countries worldwide adopted nationwide lockdowns to observe social distancing as a measure to contain the spread. This led to disruption, limitation, challenges, and changes in each sector of every industry. Similarly, the healthcare analytical testing services industry was also impacted by the pandemic.

Segment Analysis

The global healthcare analytical testing services market is segmented based on test type by bioanalytical testing services, method development & validation, stability testing, drug substances and others. The stability testing segment held the largest market share. Stability testing is done to evaluate the capability of the drug to retain its properties throughout its shelf-life.

The stability testing is done on the basis of five parameters, chemical, physical, microbiological, therapeutic and toxicity. The degradation with respect to any of these parameters can lead to health hazards. According to the study published by Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decades. Furthermore, according to the World Health Organization, in 2019, the number of registered trials were around 92% in South East Asia and around 66% in the Eastern Mediterranean region. Hence, these factors are expected to impact positively on the market growth in this segment.

The bioanalytical testing services segment is expected to have positive market growth in the forecast period. Bioanalytical tests are used in drug discovery, drug development, and in the commercialization of drugs. In recent years, increased focus of biopharmaceutical companies on contract research development services has created opportunities in the bioanalytical testing services market. Increasing frequency of outsourcing research and development activities by many biopharmaceutical companies in order to focus on their core competencies are expected to propel the expansion of the global bioanalytical testing services market during the forecast period. Moreover, cost-effectiveness of outsourcing compared to in-house analysis is likely to further drive the market.

Bioanalytical testing services supports development of drugs in various geographies and for various different therapeutic areas. Bioanalytical testing enables quantitative determination of drugs in biological substances such as blood, serum, plasma, or urine. All these tests are conducted in pathological labs or diagnostic centers and in research laboratories. It is conducted when a drug is being developed, and helps in the commercialization of the drug sells. Pharmaceutical and biopharmaceutical companies are the leading end-user in bioanalytical testing services. This factor will drive the growth of the market in the forecast period.

Further, the market is also classified based on end-user as pharmaceutical & biopharmaceutical companies, medical device companies, contract research organizations. The medical device companies segment is held the largest market share. Medical devices are electronic devices that are implanted within the body to monitor the patients' medical condition. These are most widely used nowadays in order to improve the medical outcome of patients. As there is an increasing demand for medical devices due to the rising prevalence of chronic diseases, hence various companies are shifting their focus on research and development and outsourcing of medical devices. Therefore the medical device companies are launching new devices in the market. This factor will drive the growth of the market in the forecast period.

Geographical Presentation

By region, the healthcare analytical testing services market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global healthcare analytical testing services market and is expected to grow at the highest CAGR during the forecast period due to presence of large number of key players operating in the healthcare analytical testing services market.

According to the clinical trials in 2019, around 293,321 studies were registered during the start of the year and around 32,523 at the end of year. Furthermore, in 2019, approximately 48 novel drugs were approved as per the data of the FDA's Center for Drug Evaluation and Research (CDER).

According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies were around 79.6 billion USD in the United States. Thus, the increasing number of clinical trials and number of approved drugs is expected to boost up the demand of pharmaceutical analytical testing market growth in the region.

The Asia-Pacific region is expected to have third-largest share due to creasing R&D in this region, and increasing adoption of new technology in healthcare analytical testing. Furthermore, the Owing to the increasing prevalence of chronic diseases the demand for the service is also rising. These factors stimulate market growth over the forecasted period in the region.

Competitive Analysis

The healthcare analytical testing services market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition Laboratory Testing Inc., Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc. and Steris are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for the healthcare analytical testing services market across the globe. For instance,

  • In June 2019, Eurofins Scientific acquired Transplant Genomics Inc. (US) to expand its transplantation testing footprint.
  • In May 2019, SGS acquired Chemical Solutions Ltd. (CSL) (US), a testing laboratory specializing in elemental and heavy metal testing for food, nutraceuticals, pharma, and cosmetic products
  • In December 2019, Frontage Labs partnered with J&J Corporate Services, Inc. (US) to expand its foothold in Canada and the west coast of North America.
  • In March 2018, Charles River Laboratories added 2,800-ft2 of cleanrooms dedicated to GMP microbial and mammalian cell banking at its site in Malvern, Pennsylvania.

Why Purchase the Report?

  • Visualize the composition of the global healthcare analytical testing services market products in terms of test type and end user highlights the critical commercial assets and players.
  • Identify commercial opportunities in the global healthcare analytical testing services market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global healthcare analytical testing services market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • *The global healthcare analytical testing services market report will provide access to approximately 50 market data tables, 44 figures, and 200 pages

Target Audience2022

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Table of Contents

1. Global Healthcare Analytical Testing services Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Healthcare Analytical Testing Market - Market Definition and Overview

3. Global Healthcare Analytical Testing Market - Executive Summary

  • 3.1. Market Snippet by Test Type
  • 3.2. Market Snippet by End User
  • 3.3. Market Snippet by Region

4. Global Healthcare Analytical Testing Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number of Clinical Trials
      • 4.1.1.2. Focus on Analytical Testing of Biologics & Biosimilars
    • 4.1.2. Restraints
      • 4.1.2.1. Data Insecurity
  • 4.2. Impact Analysis
  • 4.3. Opportunity

5. Global Healthcare Analytical Testing Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Analysis
  • 5.6. Post Sales Services Analysis
  • 5.7. COVID-19 Impact Analysis

6. Global Healthcare Analytical Testing Market - By Test Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 6.3. Market Attractiveness Index, By Test Type
    • 6.3.1. Bioanalytical Testing Services *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 6.3.2. Method Development & Validation
    • 6.3.3. Stability Testing
    • 6.3.4. Drug Substances
    • 6.3.5. Others

7. Global Healthcare Analytical Testing Market - By End-User

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 7.3. Market Attractiveness Index, By End-User
      • 7.3.1.1. Pharmaceutical & Biopharmaceutical Companies
      • 7.3.1.2. Introduction
      • 7.3.1.3. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 7.3.2. Medical Device Companies
    • 7.3.3. Contract Research Organizations

8. Global Healthcare Analytical Testing Market - By Region

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 8.3. Market Attractiveness Index, By Region
  • 8.4. North America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. U.S.
      • 8.4.5.2. Canada
      • 8.4.5.3. Mexico
  • 8.5. Europe
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. Germany
      • 8.5.5.2. U.K.
      • 8.5.5.3. France
      • 8.5.5.4. Rest of Europe
  • 8.6. South America
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.6.5.1. Brazil
      • 8.6.5.2. Argentina
      • 8.6.5.3. Rest of South America
  • 8.7. Asia Pacific
    • 8.7.1. Introduction
    • 8.7.2. Key Region-Specific Dynamics
    • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.7.5.1. China
      • 8.7.5.2. India
      • 8.7.5.3. Japan
      • 8.7.5.4. Australia
      • 8.7.5.5. Rest of Asia Pacific
  • 8.8. Middle East and Africa
    • 8.8.1. Introduction
    • 8.8.2. Key Region-Specific Dynamics
    • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9. Global Healthcare Analytical Testing Market Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Global Healthcare Analytical Testing Market Company Profiles

  • 10.1. Laboratory Testing Inc *
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Developments
    • 10.1.4. Financial Overview
  • 10.2. Eurofins Scientific
  • 10.3. SGS SA
  • 10.4. Toxikon Inc.
  • 10.5. Pace Analytical Services
  • 10.6. Intertek Pharmaceutical Services
  • 10.7. Boston Analytical
  • 10.8. West Pharmaceutical Services Inc. a
  • 10.9. Steris
  • 10.10. Charles River Laboratories
  • List is not exhaustive

11. Global Healthcare Analytical Testing Market - Premium Insights

12. Global Healthcare Analytical Testing Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.